196 related articles for article (PubMed ID: 23199413)
1. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review.
Godfrey EM; Folger SG; Jeng G; Jamieson DJ; Curtis KM
Contraception; 2013 May; 87(5):549-66. PubMed ID: 23199413
[TBL] [Abstract][Full Text] [Related]
2. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Christelle K; Norhayati MN; Jaafar SH
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD006034. PubMed ID: 36017945
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine device use among women with uterine fibroids: a systematic review.
Zapata LB; Whiteman MK; Tepper NK; Jamieson DJ; Marchbanks PA; Curtis KM
Contraception; 2010 Jul; 82(1):41-55. PubMed ID: 20682142
[TBL] [Abstract][Full Text] [Related]
4. Treatment of increased menstrual blood loss in IUD users.
Toppozada M
Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use.
Grimes DA; Hubacher D; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD006034. PubMed ID: 17054271
[TBL] [Abstract][Full Text] [Related]
6. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
7. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
8. The effect of vitamin B1 on bleeding and spotting in women using an intrauterine device: a double-blind randomised controlled trial.
Jafari A; Abedi P; Sayahi M; Torkashvand R
Eur J Contracept Reprod Health Care; 2014 Jun; 19(3):180-6. PubMed ID: 24738933
[TBL] [Abstract][Full Text] [Related]
9. Nonsurgical management of heavy menstrual bleeding: a systematic review.
Matteson KA; Rahn DD; Wheeler TL; Casiano E; Siddiqui NY; Harvie HS; Mamik MM; Balk EM; Sung VW;
Obstet Gynecol; 2013 Mar; 121(3):632-643. PubMed ID: 23635628
[TBL] [Abstract][Full Text] [Related]
10. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
11. IUD-induced uterine bleeding.
El-badrawi HH; Hafez ES
Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
[TBL] [Abstract][Full Text] [Related]
12. Antifibrinolytics for heavy menstrual bleeding.
Cooke I; Lethaby A; Farquhar C
Cochrane Database Syst Rev; 2000; (2):CD000249. PubMed ID: 10796518
[TBL] [Abstract][Full Text] [Related]
13. Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.
Hubacher D; Reyes V; Lillo S; Pierre-Louis B; Zepeda A; Chen PL; Croxatto H
Hum Reprod; 2006 Jun; 21(6):1467-72. PubMed ID: 16484309
[TBL] [Abstract][Full Text] [Related]
14. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhage induced by intrauterine devices: control by local proteinase inhibition.
Tauber PF; Wolf AS; Herting W; Zaneveld LJ
Fertil Steril; 1977 Dec; 28(12):1375-7. PubMed ID: 590549
[TBL] [Abstract][Full Text] [Related]
16. The safety of intrauterine devices in breastfeeding women: a systematic review.
Berry-Bibee EN; Tepper NK; Jatlaoui TC; Whiteman MK; Jamieson DJ; Curtis KM
Contraception; 2016 Dec; 94(6):725-738. PubMed ID: 27421765
[TBL] [Abstract][Full Text] [Related]
17. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
[TBL] [Abstract][Full Text] [Related]
18. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Bengtsson LP; Weström L
Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review.
Tepper NK; Steenland MW; Marchbanks PA; Curtis KM
Contraception; 2013 May; 87(5):639-44. PubMed ID: 23040123
[TBL] [Abstract][Full Text] [Related]
20. Adolescent Experiences With Intrauterine Devices: A Qualitative Study.
Schmidt EO; James A; Curran KM; Peipert JF; Madden T
J Adolesc Health; 2015 Oct; 57(4):381-6. PubMed ID: 26126950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
